Allopurinol should not be administered to individuals known to be hypersensitive to allopurinol or to any of the components of the formulation, listed in section 6.1.
Identical in all 5 labels. Surrounding text shown from Tillomed Laboratories Ltd.
This medicine should not be administered to individuals known to be hypersensitive to allopurinol or to any of the components of the formulation, listed in section 6.1.
Allopurinol oral suspension should not be administered to individuals known to be hypersensitive to allopurinol or to any of the components of the formulation, listed in section 6.1.
Elevated concentrations of metabolite oxypurinol is reported to be linked to an increased risk of allopurinol hypersensitivity.
Allopurinol should not be administered to individuals known to be hypersensitive to the active substance or to any of the excipients listed in section 6.1.
Zyloric should not be administered to individuals known to be hypersensitive to allopurinol or to any of the components of the formulation, listed in section 6.1.
Allergy to the medicine · Allopurinol · Interchangeable?